Medical Tactile Inc. (MTI) -- a medical device company specializing in tactile sensing technology -- signed a long-term partnership agreement with Sino Tau International Co, Ltd. -- one of China's leading medical device distributors.

Under the terms of agreement, Sino Tau will market, sell and service Medical Tactile's SureTouch Visual Mapping System in China and other Asian countries (excluding Japan). The agreement involves a minimum of 650 SureTouch units over the next three years, with deliveries beginning during the second quarter of 2006. In addition to serving as Medical Tactile's primary Asian distributor, Sino Tau will work with the company to initiate a multi-centre breast cancer screening clinical trial in China later this year.

Introduced in December 2005, the SureTouch system electronically documents the results of clinical breast exams, which are the most accessible first-line of defense against breast cancer for most women. Based on Medical Tactile's proprietary tactile sensing technology, the system is designed to improve the sensitivity, specificity and objectivity of such exams.

"We are pleased to join forces with Sino Tau to launch MTI's SureTouch system in Asia," Steve Weiss, CEO of Medical Tactile, Inc. said adding, "Sino Tau understands the region's large and still-growing market for breast cancer screening, and has the specific clinical and medical device experience necessary to ensure a successful product launch."

Breast cancer is the leading cause of death for women in China, accounting for about 300,000 deaths each year. The incidence has increased in recent years, from 17 per 100,000 in 1999 to 52 per 100,000 in 2003.